Skip to main content

Advertisement

SpringerLink
Log in

Issues to be considered to address the future liver remnant prior to major hepatectomy

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

An accurate preoperative evaluation of the hepatic function and application of portal vein embolization in selected patients have helped improve the safety of major hepatectomy. In planning major hepatectomy, however, several issues remain to be addressed. The first is which cut-off values for serum total bilirubin level and prothrombin time should be used to define post-hepatectomy liver failure. Other issues include what minimum future liver remnant (FLR) volume is required; whether the total liver volume measured using computed tomography or the standard liver volume calculated based on the body surface area should be used to assess the adequacy of the FLR volume; whether there is a discrepancy between the FLR volume and function during the recovery period after portal vein embolization or hepatectomy; and how best the function of a specific FLR can be assessed. Various studies concerning these issues have been reported with controversial results. We should also be aware that different strategies and management are required for different types of liver damage, such as cirrhosis in hepatocellular carcinoma, cholangitis in biliary tract cancer, and chemotherapy-induced hepatic injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Otsubo T, Kobayashi S, Sano K, Misawa T, Ota T, Katagiri S, et al. Safety-related outcomes of the Japanese Society of Hepato-Biliary-Pancreatic Surgery board certification system for expert surgeons. J Hepatobil Pancreat Sci. 2017;24:252–61.

    Google Scholar 

  2. de Santibanes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg. 2012;255:415–7.

    PubMed  Google Scholar 

  3. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14.

    PubMed  Google Scholar 

  4. Chan A, Zhang WY, Chok K, Dai J, Ji R, Kwan C, et al. ALPPS versus portal vein embolization for hepatitis-related hepatocellular carcinoma: a changing paradigm in modulation of future liver remnant before major hepatectomy. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003433.

    Article  PubMed  Google Scholar 

  5. Makuuchi M, Takayasu K, Takuma T, Yamazaki S, Hasegawa H, Nishiura S, et al. Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma. J Jpn Soc Clin Surg. 1984;45:14–20(in Japanese).

    Google Scholar 

  6. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803–8.

    CAS  PubMed  Google Scholar 

  7. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.

    CAS  PubMed  Google Scholar 

  8. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589–94.

    CAS  PubMed  Google Scholar 

  9. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–8 discussion 8–9.

    PubMed  PubMed Central  Google Scholar 

  10. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–62 discussion 62–64.

    PubMed  Google Scholar 

  11. Wang HQ, Yang J, Yang JY, Wang WT, Yan LN. Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy. World J Gastroenterol. 2014;20:11871–7.

    PubMed  PubMed Central  Google Scholar 

  12. Ribero D, Zimmitti G, Aloia TA, Shindoh J, Fabio F, Amisano M, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg. 2016;223:87–97.

    PubMed  PubMed Central  Google Scholar 

  13. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24.

    PubMed  Google Scholar 

  14. Kaneko K, Shirai Y, Wakai T, Yokoyama N, Akazawa K, Hatakeyama K. Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma. World J Gastroenterol. 2005;11:5888–92.

    PubMed  PubMed Central  Google Scholar 

  15. Rahbari NN, Reissfelder C, Koch M, Elbers H, Striebel F, Buchler MW, et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann Surg Oncol. 2011;18:3640–9.

    PubMed  Google Scholar 

  16. Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg. 2011;35:2073–82.

    PubMed  Google Scholar 

  17. Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC 2nd, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg. 2011;212:638–48 discussion 48–50.

    PubMed  PubMed Central  Google Scholar 

  18. Tomimaru Y, Eguchi H, Gotoh K, Kawamoto K, Wada H, Asaoka T, et al. Platelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocellular carcinoma than indocyanine green clearance test. J Surg Oncol. 2016;113:565–9.

    PubMed  Google Scholar 

  19. Venkat R, Hannallah JR, Krouse RS, Maegawa FB. Preoperative thrombocytopenia and outcomes of hepatectomy for hepatocellular carcinoma. J Surg Res. 2016;201:498–505.

    PubMed  Google Scholar 

  20. Golriz M, Ghamarnejad O, Khajeh E, Sabagh M, Mieth M, Hoffmann K, et al. Preoperative Thrombocytopenia May Predict Poor Surgical Outcome after Extended Hepatectomy. Can J Gastroenterol Hepatol. 2018;2018:1275720.

    PubMed  PubMed Central  Google Scholar 

  21. Navarro JG, Yang SJ, Kang I, Choi GH, Han DH, Kim KS, et al. What are the most important predictive factors for clinically relevant posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma? Ann Surg Treat Res. 2020;98:62–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–26.

    PubMed  Google Scholar 

  23. Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11:1–30.

    PubMed  Google Scholar 

  24. Ichikawa T, Uenishi T, Takemura S, Oba K, Ogawa M, Kodai S, et al. A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:42–8.

    PubMed  Google Scholar 

  25. Ratti F, Cipriani F, Catena M, Paganelli M, Aldrighetti L. Liver failure in patients treated with chemotherapy for colorectal liver metastases: Role of chronic disease scores in patients undergoing major liver surgery. A case-matched analysis. Eur J Surg Oncol. 2014;40:1550-6.

  26. Mai RY, Ye JZ, Long ZR, Shi XM, Bai T, Chen J, et al. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res. 2019;11:1401–14.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–16.

    PubMed  Google Scholar 

  28. Soubrane O, Brouquet A, Zalinski S, Terris B, Brezault C, Mallet V, et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg. 2010;251:454–60.

    PubMed  Google Scholar 

  29. Overman MJ, Ferrarotto R, Raghav K, George B, Qiao W, Machado KK, et al. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. J Natl Cancer Inst. 2018;110:888–94.

    PubMed  Google Scholar 

  30. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg. 2010;251:300–6.

    PubMed  Google Scholar 

  31. Takahashi K, Kurokawa T, Oshiro Y, Fukunaga K, Sakashita S, Ohkohchi N. Postoperative decrease in platelet counts is associated with delayed liver function recovery and complications after partial hepatectomy. Tohoku J Exp Med. 2016;239:47–55.

    PubMed  Google Scholar 

  32. Margonis GA, Amini N, Buettner S, Besharati S, Kim Y, Sobhani F, et al. Impact of early postoperative platelet count on volumetric liver gain and perioperative outcomes after major liver resection. Br J Surg. 2016;103:899–907.

    CAS  PubMed  Google Scholar 

  33. Starlinger P, Haegele S, Offensperger F, Oehlberger L, Pereyra D, Kral JB, et al. The profile of platelet alpha-granule released molecules affects postoperative liver regeneration. Hepatology. 2016;63:1675–88.

    CAS  PubMed  Google Scholar 

  34. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81.

    CAS  PubMed  Google Scholar 

  35. Monaco AP, Hallgrimsson J, McDermott WV Jr. multiple adenoma (hamartoma) of the liver treated by subtotal (90 percent) resection: morphological and functional studies of regeneration. Ann Surg. 1964;159:513–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Starzl TE, Putnam CW, Groth CG, Corman JL, Taubman J. Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg. 1975;129:587–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg. 1987;206:30–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery. 2004;135:404–10.

    PubMed  Google Scholar 

  39. Shoup M, Gonen M, D’Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325–30.

    PubMed  Google Scholar 

  40. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54:289–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Ferrero A, Vigano L, Polastri R, Muratore A, Eminefendic H, Regge D, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg. 2007;31:1643–51.

    PubMed  Google Scholar 

  42. Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250(4):540–8.

    PubMed  Google Scholar 

  43. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–9.

    CAS  PubMed  Google Scholar 

  44. Yamashita S, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, et al. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases. J Hepatol. 2017;67:56–64.

    PubMed  Google Scholar 

  45. Ribero D, Amisano M, Bertuzzo F, Langella S, Lo Tesoriere R, Ferrero A, et al. Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use? Ann Surg. 2013;258:801–6.

    PubMed  Google Scholar 

  46. Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Cho CK, et al. Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean J Hepatobiliary Pancreat Surg. 2013;17:143–51.

    PubMed  PubMed Central  Google Scholar 

  47. Olthof PB, van Dam R, Jovine E, Campos RR, de Santibanes E, Oldhafer K, et al. Accuracy of estimated total liver volume formulas before liver resection. Surgery. 2019;166:247–53.

    PubMed  Google Scholar 

  48. Kubota K, Aoki T, Kumamaru H, Shiraki T, Miyata H, Seto Y, et al. Use of the National Clinical Database to evaluate the association between preoperative liver function and postoperative complications among patients undergoing hepatectomy. J Hepatobiliary Pancreat Sci. 2019;26:331–40.

    PubMed  Google Scholar 

  49. Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg. 1996;223:77–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg. 2011;98:825–34.

    PubMed  Google Scholar 

  51. Nadalin S, Testa G, Malago M, Beste M, Frilling A, Schroeder T, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl. 2004;10:1024–9.

    PubMed  Google Scholar 

  52. Aoki T, Imamura H, Matsuyama Y, Kishi Y, Kobayashi T, Sugawara Y, et al. Convergence process of volumetric liver regeneration after living-donor hepatectomy. J Gastrointest Surg. 2011;15:1594–601.

    PubMed  Google Scholar 

  53. Maeda T, Yokoyama Y, Ebata T, Igami T, Mizuno T, Yamaguchi J, et al. Discrepancy between volume and functional recovery in early phase liver regeneration following extended hepatectomy with extrahepatic bile duct resection. Hepatol Res. 2019;49:1227–35.

    CAS  PubMed  Google Scholar 

  54. Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013;216:201–9.

    PubMed  Google Scholar 

  55. Watanabe N, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, et al. A predictive scoring system for insufficient liver hypertrophy after preoperative portal vein embolization. Surgery. 2018;163:1014–9.

    PubMed  Google Scholar 

  56. Shi JH, Hammarstrom C, Grzyb K, Line PD. Experimental evaluation of liver regeneration patterns and liver function following ALPPS. BJS Open. 2017;1:84–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.

    PubMed  PubMed Central  Google Scholar 

  58. Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260–8.

    CAS  PubMed  Google Scholar 

  59. Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Yamaguchi J, et al. The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg. 2016;40:1440–7.

    PubMed  Google Scholar 

  60. Olthof PB, Tomassini F, Huespe PE, Truant S, Pruvot FR, Troisi RI, et al. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: liver volume overestimates liver function. Surgery. 2017;162:775–83.

    PubMed  Google Scholar 

  61. Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol. 1974;41:99–128.

    CAS  PubMed  Google Scholar 

  62. Krishnamurthy S, Krishnamurthy GT. Technetium-99 m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology. Hepatology. 1989;9:139–53.

    CAS  PubMed  Google Scholar 

  63. Kwon AH, Matsui Y, Kaibori M, Ha-Kawa SK. Preoperative regional maximal removal rate of technetium-99 m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery. 2006;140:379–86.

    PubMed  Google Scholar 

  64. Iimuro Y, Kashiwagi T, Yamanaka J, Hirano T, Saito S, Sugimoto T, et al. Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99 mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci. 2010;17:673–81.

    PubMed  Google Scholar 

  65. de Graaf W, van Lienden KP, Dinant S, Roelofs JJ, Busch OR, Gouma DJ, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg. 2010;14:369–78.

    PubMed  Google Scholar 

  66. Chapelle T, Beeck B, Driessen A, Roeyen G, Bracke B, Hartman V, et al. Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores. Eur J Surg Oncol. 2017;43:2277–84.

    CAS  PubMed  Google Scholar 

  67. Sumiyoshi T, Shima Y, Tokorodani R, Okabayashi T, Kozuki A, Hata Y, et al. CT/99 mTc-GSA SPECT fusion images demonstrate functional differences between the liver lobes. World J Gastroenterol. 2013;19:3217–25.

    PubMed  PubMed Central  Google Scholar 

  68. Morine Y, Enkhbold C, Imura S, Ikemoto T, Iwahashi S, Saito YU, et al. Accurate estimation of functional liver volume using Gd-EOB-DTPA MRI compared to MDCT/(99m)Tc-SPECT fusion imaging. Anticancer Res. 2017;37:5693–700.

    CAS  PubMed  Google Scholar 

  69. Kim DK, Choi JI, Choi MH, Park MY, Lee YJ, Rha SE, et al. Prediction of posthepatectomy liver failure: mri with hepatocyte-specific contrast agent versus indocyanine green clearance test. AJR Am J Roentgenol. 2018;211:580–7.

    PubMed  Google Scholar 

  70. Asenbaum U, Kaczirek K, Ba-Ssalamah A, Ringl H, Schwarz C, Waneck F, et al. Post-hepatectomy liver failure after major hepatic surgery: not only size matters. Eur Radiol. 2018;28:4748–56.

    PubMed  PubMed Central  Google Scholar 

  71. Tomassini F, D’Asseler Y, Linecker M, Giglio MC, Castro-Benitez C, Truant S, et al. Hepatobiliary scintigraphy and kinetic growth rate predict liver failure after ALPPS: a multi-institutional study. HPB (Oxford). 2020. https://doi.org/10.1016/j.hpb.2020.01.010.

    Article  Google Scholar 

  72. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg. 2002;137:675–80 discussion 80–1.

    PubMed  Google Scholar 

  73. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003;237:686–91 discussion 91–93.

    PubMed  PubMed Central  Google Scholar 

  74. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677–83.

    PubMed  PubMed Central  Google Scholar 

  75. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240:1037–49 discussion 49–51.

    PubMed  PubMed Central  Google Scholar 

  76. Sandstrom P, Rosok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, et al. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a scandinavian multicenter randomized controlled trial (LIGRO Trial). Ann Surg. 2018;267:833–40.

    PubMed  Google Scholar 

  77. Gall TM, Sodergren MH, Frampton AE, Fan R, Spalding DR, Habib NA, et al. Radio-frequency-assisted Liver Partition with Portal vein ligation (RALPP) for liver regeneration. Ann Surg. 2015;261:e45–6.

    PubMed  Google Scholar 

  78. Jiao LR, Fajardo Puerta AB, Gall TMH, Sodergren MH, Frampton AE, Pencavel T, et al. Rapid induction of liver regeneration for major hepatectomy (REBIRTH): a randomized controlled trial of portal vein embolisation versus ALPPS assisted with radiofrequency. Cancers (Basel). 2019;11:302. https://doi.org/10.3390/cancers11030302

    Article  Google Scholar 

  79. Robles R, Parrilla P, Lopez-Conesa A, Brusadin R, de la Pena J, Fuster M, et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg. 2014;101:1129–34 discussion 34.

    CAS  PubMed  Google Scholar 

  80. Petrowsky H, Gyori G, de Oliveira M, Lesurtel M, Clavien PA. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg. 2015;261:e90–2.

    PubMed  Google Scholar 

  81. Sakamoto Y, Inagaki F, Omichi K, Ohkura N, Hasegawa K, Kokudo N. Associating liver partial partition and transileocecal portal vein embolization for staged hepatectomy. Ann Surg. 2016;264:e21–2.

    PubMed  Google Scholar 

  82. Schlegel A, Lesurtel M, Melloul E, Limani P, Tschuor C, Graf R, et al. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg. 2014;260:839–46.

    PubMed  Google Scholar 

  83. Garcia-Perez R, Revilla-Nuin B, Martinez CM, Bernabe-Garcia A, BarojaMazo A. ParrillaParicio P (2015) Associated liver partition and portal vein ligation (ALPPS) vs selective portal vein ligation (PVL) for staged hepatectomy in a rat model Similar Regenerative Response? PLoS ONE. 2015;10:e0144096.

    PubMed  PubMed Central  Google Scholar 

  84. Langiewicz M, Schlegel A, Saponara E, Linecker M, Borger P, Graf R, et al. Hedgehog pathway mediates early acceleration of liver regeneration induced by a novel two-staged hepatectomy in mice. J Hepatol. 2017;66:560–70.

    CAS  PubMed  Google Scholar 

  85. Tanaka K, Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. Eur J Surg Oncol. 2015;41:506–12.

    CAS  PubMed  Google Scholar 

  86. Sparrelid E, Jonas E, Tzortzakakis A, Dahlen U, Murquist G, Brismar T, et al. Dynamic evaluation of liver volume and function in associating liver partition and portal vein ligation for staged hepatectomy. J Gastrointest Surg. 2017;21:967–74.

    PubMed  PubMed Central  Google Scholar 

  87. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005;16:215–25.

    PubMed  Google Scholar 

  88. Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, et al. Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery. 2008;144:744–51.

    PubMed  Google Scholar 

  89. Ito J, Komada T, Suzuki K, Matsushima M, Nakatochi M, Kobayashi Y, et al. Evaluation of segment 4 portal vein embolization added to right portal vein for right hepatic trisectionectomy: A retrospective propensity score-matched study. J Hepatobiliary Pancreat Sci. 2020.

  90. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg. 2004;139:766–74.

    PubMed  Google Scholar 

  91. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93:1091–8.

    CAS  PubMed  Google Scholar 

  92. Nagino M, Yamada T, Kamiya J, Uesaka K, Arai T, Nimura Y. Left hepatic trisegmentectomy with right hepatic vein resection after right hepatic vein embolization. Surgery. 2003;133:580–2.

    PubMed  Google Scholar 

  93. Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg. 2009;249:608–16.

    PubMed  Google Scholar 

  94. Panaro F, Giannone F, Riviere B, Sgarbura O, Cusumano C, Deshayes E, et al. Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr. 2019;8:329–37.

    PubMed  PubMed Central  Google Scholar 

  95. Kobayashi K, Yamaguchi T, Denys A, Perron L, Halkic N, Demartines N, et al. Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: a single center experience. Surgery. 2020;167:917–23.

    PubMed  Google Scholar 

  96. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–94.

    CAS  PubMed  Google Scholar 

  97. Guiu B, Quenet F, Escal L, Bibeau F, Piron L, Rouanet P, et al. Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol. 2017;27:3343–52.

    PubMed  Google Scholar 

  98. Vauthey JN. Liver venous deprivation: optimizing liver regeneration with combined inflow and outflow venous occlusion of the liver. Surgery. 2020;167:924-5.

  99. Erdogan D, Heijnen BH, Bennink RJ, Kok M, Dinant S, Straatsburg IH, et al. Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test. Liver Int. 2004;24:117–23.

    CAS  PubMed  Google Scholar 

  100. Chapelle T, Beeck B, Huyghe I, Francque S, Driessen A, Roeyen G, et al. Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure? HPB (Oxford). 2016;18:494–503.

    Google Scholar 

  101. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329–38.

    CAS  PubMed  Google Scholar 

  102. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018–22.

    CAS  PubMed  Google Scholar 

  103. Mai RY, Zeng J, Lu HZ, Liang R, Lin Y, Piao XM, et al. Combining aspartate aminotransferase-to-platelet ratio index with future liver remnant to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma. J Gastrointest Surg. 2020. https://doi.org/10.1007/s11605-020-04575-w.

    Article  PubMed  Google Scholar 

  104. Kabir T, Syn NL, Tan ZZX, Tan HJ, Yen C, Koh YX, et al. Predictors of post-operative complications after surgical resection of hepatocellular carcinoma and their prognostic effects on outcome and survival: a propensity-score matched and structural equation modelling study. Eur J Surg Oncol. 2020;46:1756–65.

    PubMed  Google Scholar 

  105. Yamashita S, Sakamoto Y, Yamamoto S, Takemura N, Omichi K, Shinkawa H, et al. Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases. Ann Surg Oncol. 2017;24:1557–68.

    PubMed  Google Scholar 

  106. Takagi T, Yokoyama Y, Kokuryo T, Yamaguchi J, Nagino M. Liver regeneration following experimental major hepatectomy with choledochojejunostomy. Br J Surg. 2015;102:1410–7.

    CAS  PubMed  Google Scholar 

  107. Takagi T, Yokoyama Y, Kokuryo T, Ebata T, Ando M, Nagino M. A clear difference between the outcomes after a major hepatectomy with and without an extrahepatic bile duct resection. World J Surg. 2017;41:508–15.

    PubMed  Google Scholar 

  108. Hochwald SN, Burke EC, Jarnagin WR, Fong Y, Blumgart LH. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 1999;134:261–6.

    CAS  PubMed  Google Scholar 

  109. Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg. 2000;135:302–8.

    CAS  PubMed  Google Scholar 

  110. Laurent A, Tayar C, Cherqui D. Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford). 2008;10:126–9.

    CAS  Google Scholar 

  111. Ferrero A, Lo Tesoriere R, Vigano L, Caggiano L, Sgotto E, Capussotti L. Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg. 2009;33:318–25.

    PubMed  Google Scholar 

  112. Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100:274–83.

    CAS  PubMed  Google Scholar 

  113. Olthof PB, Wiggers JK, Groot Koerkamp B, Coelen RJ, Allen PJ, Besselink MG, et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J Am Coll Surg. 2017;225:387–94.

    PubMed  Google Scholar 

  114. Watanabe Y, Kuboki S, Shimizu H, Ohtsuka M, Yoshitomi H, Furukawa K, et al. A new proposal of criteria for the future remnant liver volume in older patients undergoing major hepatectomy for biliary tract cancer. Ann Surg. 2018;267:338–45.

    PubMed  Google Scholar 

  115. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–6.

    CAS  PubMed  Google Scholar 

  116. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274–86.

    CAS  PubMed  Google Scholar 

  117. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg. 2008;247:118–24.

    PubMed  Google Scholar 

  118. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–72.

    CAS  PubMed  Google Scholar 

  119. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem. 2001;49:121–30.

    CAS  PubMed  Google Scholar 

  120. Van Buren G, Yang AD, Dallas NA, Gray MJ, Lim SJ, Xia L, et al. Effect of molecular therapeutics on liver regeneration in a murine model. J Clin Oncol. 2008;26:1836–42.

    PubMed  Google Scholar 

  121. Ellis LM, Curley SA, Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol. 2005;23:4853–5.

    CAS  PubMed  Google Scholar 

  122. Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol. 2008;15:2765–72.

    PubMed  PubMed Central  Google Scholar 

  123. Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. 2009;16:1553–9.

    PubMed  Google Scholar 

  124. Millet G, Truant S, Leteurtre E, Hebbar M, Zerbib P, Huet G, et al. Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a case-matched study in 82 patients. Ann Surg. 2012;256:755–61.

    PubMed  Google Scholar 

  125. Margonis GA, Buettner S, Andreatos N, Sasaki K, Pour MZ, Deshwar A, et al. Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases. J Surg Oncol. 2017;116:1150–8.

    CAS  PubMed  Google Scholar 

  126. Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007;110:2761–7.

    PubMed  Google Scholar 

  127. Klinger M, Eipeldauer S, Hacker S, Herberger B, Tamandl D, Dorfmeister M, et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol. 2009;35:515–20.

    CAS  PubMed  Google Scholar 

  128. Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D, et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2010;17:2870–6.

    PubMed  Google Scholar 

  129. Elias D, De Baere T, Roche A, Mducreux, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86:784–8.

    CAS  PubMed  Google Scholar 

  130. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001;34:267–72.

    CAS  PubMed  Google Scholar 

  131. Hoekstra LT, van Lienden KP, Doets A, Busch OR, Gouma DJ, van Gulik TM. Tumor progression after preoperative portal vein embolization. Ann Surg. 2012;256:812–7.

    PubMed  Google Scholar 

  132. Takamoto T, Hashimoto T, Sano K, Maruyama Y, Inoue K, Ogata S, et al. Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis. Ann Surg Oncol. 2010;17:2747–55.

    PubMed  Google Scholar 

  133. Omichi K, Yamashita S, Cloyd JM, Shindoh J, Mizuno T, Chun YS, et al. Portal vein embolization reduces postoperative hepatic insufficiency associated with postchemotherapy hepatic atrophy. J Gastrointest Surg. 2018;22:60–7.

    PubMed  Google Scholar 

  134. Simoneau E, Hassanain M, Shaheen M, Aljiffry M, Molla N, Chaudhury P, et al. Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases. Br J Surg. 2015;102:1240–9.

    CAS  PubMed  Google Scholar 

  135. Huiskens J, Olthof PB, van der Stok EP, Bais T, van Lienden KP, Moelker A, et al. Does portal vein embolization prior to liver resection influence the oncological outcomes—a propensity score matched comparison. Eur J Surg Oncol. 2018;44:108–14.

    PubMed  Google Scholar 

  136. Collin Y, Pare A, Belblidia A, Letourneau R, Plasse M, Dagenais M, et al. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: a prospective cohort study. Int J Surg. 2019;61:42–7.

    PubMed  Google Scholar 

  137. Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009;11:445–51.

    PubMed  PubMed Central  Google Scholar 

  138. Ribeiro HS, Costa WL Jr, Diniz AL, Godoy AL, Herman P, Coudry RA, et al. Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis. Eur J Surg Oncol. 2013;39:380–5.

    CAS  PubMed  Google Scholar 

  139. Dumitrascu T, Brasoveanu V, Stroescu C, Ionescu M, Popescu I. Major hepatectomies for perihilar cholangiocarcinoma: predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions. Asian J Surg. 2016;39:81–9.

    PubMed  Google Scholar 

  140. Lordan JT, Worthington TR, Quiney N, Fawcett WJ, Karanjia ND. Operative mortality, blood loss and the use of Pringle manoeuvres in 526 consecutive liver resections. Ann R Coll Surg Engl. 2009;91:578–82.

    PubMed  PubMed Central  Google Scholar 

  141. Palavecino M, Kishi Y, Chun YS, Brown DL, Gottumukkala VN, Lichtiger B, et al. Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery. 2010;147:40–8.

    PubMed  Google Scholar 

  142. Ichida A, Hasegawa K, Takayama T, Kudo H, Sakamoto Y, Yamazaki S, et al. Randomized clinical trial comparing two vessel-sealing devices with crush clamping during liver transection. Br J Surg. 2016;103:1795–803.

    CAS  PubMed  Google Scholar 

  143. Rahbari NN, Koch M, Zimmermann JB, Elbers H, Bruckner T, Contin P, et al. Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg. 2011;253:1102–10.

    PubMed  Google Scholar 

  144. Zhu P, Lau WY, Chen YF, Zhang BX, Huang ZY, Zhang ZW, et al. Randomized clinical trial comparing infrahepatic inferior vena cava clamping with low central venous pressure in complex liver resections involving the Pringle manoeuvre. Br J Surg. 2012;99:781–8.

    CAS  PubMed  Google Scholar 

  145. Ueno M, Kawai M, Hayami S, Hirono S, Okada KI, Uchiyama K, et al. Partial clamping of the infrahepatic inferior vena cava for blood loss reduction during anatomic liver resection: a prospective, randomized, controlled trial. Surgery. 2017;161:1502–13.

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Stephanie P Deming from the Department of Scientific Publications, MD Anderson Cancer Center, for editing a draft of this manuscript.

Author information

Authors and Affiliations

  1. Department of Surgery, National Defense Medical College, Namiki 3-2, Tokorozawa, Saitama, 359-8513, Japan

    Yoji Kishi

  2. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Jean-Nicolas Vauthey

Authors
  1. Yoji Kishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Nicolas Vauthey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoji Kishi.

Ethics declarations

Conflict of interest

Yoji Kishi and other co-authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kishi, Y., Vauthey, JN. Issues to be considered to address the future liver remnant prior to major hepatectomy. Surg Today 51, 472–484 (2021). https://doi.org/10.1007/s00595-020-02088-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-020-02088-2

Keywords

Search

Navigation